iRhythm Technologies (IRTC) Expected to Announce Quarterly Earnings on Thursday

Key Points

• iRhythm Technologies is expected to report Q3 2026 results after Thursday’s market close, November 5. Analysts anticipate earnings of approximately $0.02 per share and revenue of $222.23 million.
• The company exceeded expectations in its most recent quarter, reporting $0.58 EPS versus a $0.04 loss estimate and $224.17 million in revenue, up 20.1% year over year.
• Wall Street maintains a generally positive view, with a consensus rating of “Moderate Buy” and an average price target of $177.53, compared with shares recently trading near $123.99.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) will likely be releasing its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect iRhythm Technologies to post earnings of $0.0155 per share and revenue of $222.23 million for the quarter. Interested persons can check the company's upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, November 5, 2026 at 4:30 PM ET.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.62. The business had revenue of $224.17 million during the quarter, compared to analysts' expectations of $219.30 million. iRhythm Technologies had a positive return on equity of 10.11% and a negative net margin of 1.69%. The business's revenue was up 20.1% on a year-over-year basis. During the same quarter last year, the business posted ($0.32) EPS. On average, analysts expect iRhythm Technologies to post $0.54 EPS for the current fiscal year and $1.37 EPS for the next fiscal year.

iRhythm Technologies Price Performance

Shares of IRTC stock opened at $123.99 on Thursday. The firm has a market cap of $4.09 billion, a P/E ratio of -288.35 and a beta of 1.45. iRhythm Technologies has a fifty-two week low of $100.70 and a fifty-two week high of $212.00. The business's 50 day moving average price is $115.07 and its 200-day moving average price is $123.26. The company has a debt-to-equity ratio of 3.50, a quick ratio of 3.74 and a current ratio of 3.86.

Wall Street Analyst Weigh In

A number of brokerages recently commented on IRTC. Weiss Ratings upgraded iRhythm Technologies from a "sell (e+)" rating to a "sell (d-)" rating in a report on Tuesday. Wells Fargo & Company cut their price target on shares of iRhythm Technologies from $168.00 to $150.00 and set an "overweight" rating on the stock in a report on Tuesday, October 6th. Piper Sandler initiated coverage on shares of iRhythm Technologies in a report on Friday, October 16th. They issued an "overweight" rating and a $160.00 price target on the stock. Truist Financial boosted their price objective on shares of iRhythm Technologies from $160.00 to $168.00 and gave the company a "buy" rating in a research report on Monday, August 10th. Finally, Stephens began coverage on shares of iRhythm Technologies in a report on Thursday, July 23rd. They issued an "overweight" rating and a $160.00 price objective for the company. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, iRhythm Technologies currently has a consensus rating of "Moderate Buy" and a consensus price target of $177.53.

About iRhythm Technologies

iRhythm Technologies, Inc is a digital health company focused on the diagnosis and management of cardiac arrhythmias. The company provides ambulatory cardiac monitoring services that enable physicians to evaluate patients for conditions such as atrial fibrillation and other irregular heart rhythms.

Its principal offering is the Zio platform, which combines wearable electrocardiogram (ECG) monitoring devices with cloud-based data analysis and physician reports. Products in the platform include the Zio XT, an extended-wear monitor, and the Zio AT, which provides near-real-time monitoring capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.